Skip to main content

Table 1 Healthy normal and SLE patient characteristics

From: Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy

  Group 1 Group 2
Demographic Lupus Normal Lupus Normal
Age (years) 37.87 ± 10.23 38.41 ± 13.82 46.1 ± 14.0 40.5 ± 12.4
Sex F:M 21:1 5:9 26:3 8:7
Ethnicity
African-American 15 3 19 7
Hispanic 7 0 5 0
Caucasian 0 11 6 5
Asian 0 0 0 4
Parameter     
Anti-dsDNA 10/22   18/29  
Anti-Sm 8/22   16/29  
Anti-Ro 6/22   12/29  
Anti-La 2/22   1/29  
Anti-cardiolipin 6/22   5/29  
Lupus anticoagulant 2/22   5/29  
Anti-B2 glycoprotein I 1/22   6/29  
Anti–phospholipid 3/22   3/29  
C3 low (<90) 6/22   7/29  
C4 low (<16) 5/22   8/29  
SLEDAI mean ± StDev 3.17 ± 3.13   5.6 ± 3.4